Join visionaries at Spotlight Health, the opening segment of the Aspen Ideas Festival

April 16, 2018

Hundreds of visionaries will be descending on Aspen, Colorado from June 21-24 for the Aspen Ideas Festival: Spotlight Health. This three-day health conference features an exceptional mix of inspiring and provocative experts who dive into the latest topics in medicine, science and health. Attendees are surrounded by the scenic peaks of Aspen, Colorado with plenty […]

GSK Signs Strategic Agreement To Transfer Rare Disease Gene Therapy Portfolio To Orchard Therapeutics

April 12, 2018

LONDON, April 12, 2018 (GLOBE NEWSWIRE) — GSK and Orchard Therapeutics today announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the continued development of the programmes and access for patients. This acquisition strengthens Orchard’s position as a global leader in gene […]

TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel

April 12, 2018

ZUG, Switzerland and PETACH TIKVA, Israel, April 11, 2018 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, and Medison Pharma Ltd., Israel’s leading commercial partner for innovative pharmaceuticals, today announced an exclusive distribution agreement to commercialize ZEJULA® (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, in Israel. ZEJULA is currently approved in […]

Mylan Partners with Fujifilm Kyowa Kirin Biologics to Commercialize Biosimilar to Humira® (adalimumab)

April 11, 2018

HERTFORDSHIRE, England and PITTSBURGH, April 11, 2018 /PRNewswire/ — Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced it is partnering with Fujifilm Kyowa Kirin Biologics Co., Ltd. to commercialize a biosimilar to Humira® (adalimumab) developed by Fujifilm Kyowa Kirin Biologics. Through the partnership agreement, Mylan will leverage its regulatory platform to seek approval and […]

ActiGraph Collaborates with Bayer in Mobile App Usability Pilot Study

April 11, 2018

Pensacola, FL (April 12, 2018) – ActiGraph, a leading provider of medical-grade wearable activity and sleep monitoring solutions, is collaborating with Bayer in an ongoing pilot study evaluating usability and patient perceptions of a digital tool suite consisting of Clinical Ink’s SureSource Engage mobile application, an ActiGraph activity monitor, and a Bluetooth-enabled weight scale. The […]

PAREXEL and Meiji Pharmaceutical University Announce Academic Program to Develop Japan’s Biopharmaceutical Workforce

April 10, 2018

BOSTON & TOKYO–(BUSINESS WIRE)–PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, and Meiji Pharmaceutical University (MPU), a private pharmacy and science university, today announced a new Joint Program for Clinical Research and Clinical Trial Management for undergraduate students. The academic program will offer MPU students an accredited, four-week course designed to prepare them […]

Alamo Pharma Services partners with Thingee Corporation for deployment of their iDetail™ enterprise content delivery platform for the iPad

April 5, 2018

Designed for the pharmaceutical industry, iDetail provides stunning visual display and touch interface with powerful business analytics for collecting real-time detailing call information. DOYLESTOWN, Pa. (March 28, 2018) – Alamo Pharma Services (“Alamo”) and Thingee Corporation (“Thingee”) have announced a strategic partnership utilizing Thingee’s iDetail platform that will provide Alamo sales representatives quick, seamless access […]

ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development

April 4, 2018

CAMBRIDGE, Mass. & DURHAM, N.C.–(BUSINESS WIRE)–ReForm Biologics and KBI Biopharma, Inc., (KBI) today announced a strategic partnership to make improved biopharmaceutical formulations. Through this collaboration, KBI and ReForm will help customers extend product lifecycles, enable improved dosing for patients, and enhance manufacturing efficiencies. As part of the strategic partnership, KBI has made an equity investment […]

Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio

April 3, 2018

NEW YORK & SOUTH SAN FRANCISCO–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) and Allogene Therapeutics, Inc. (Allogene) today announced that the two companies have entered into an asset contribution agreement for Pfizer’s portfolio of assets related to allogeneic chimeric antigen receptor T cell (CAR T) therapy, an investigational immune cell therapy approach to treating cancer.   “Under the […]

Quartzy and Lab Launch Inc. Partner to Make Critical Resources Available for New Labs

April 2, 2018

Quartzy joins the Los Angeles biotech non-profit as a preferred partner to provide greater accessibility to time-saving lab management solutions and necessary lab supplies Palo Alto, CA – (Apr. 2, 2018) – Quartzy, the only free online laboratory supply management and ordering platform, announced today its preferred partnership with Lab Launch Inc. to provide their […]

Alamo Pharma Services partners with Thingee Corporation for deployment of their iDetail™ enterprise content delivery platform for iPad

March 27, 2018

DOYLESTOWN, Pa. (March 27, 2018) – Alamo Pharma Services (“Alamo”) and Thingee Corporation (“Thingee”) have announced a strategic partnership utilizing Thingee’s iDetail platform that will provide Alamo Pharma’s sales representatives quick, seamless access to their most current presentations, audio/video files, and PDFs developed as sales and detailing aids. This enhanced access will allow for heightened […]

Cofactor Genomics announces new collaboration with the National Cancer Institute (NCI) to demonstrate power of RNA-based immune profiling assay

March 22, 2018

San Francisco, CA – March 20, 2018 Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National Cancer Institute, along with agreements with research groups at three other academic and pharma institutions, to demonstrate the clinical utility of their immune-profiling assay, Cofactor Paragon. These […]

Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma For Mainland China and Hong Kong

March 19, 2018

DURHAM, N.C., March 19, 2018 (GLOBE NEWSWIRE) — Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases where there is a high unmet need, entered into an agreement through its wholly owned subsidiary, AkaRx, Inc., granting Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., (Fosun Pharma Industrial), […]

The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the ‘Lab of the Future’

March 19, 2018

EU conference and two-day ‘hack the lab’ hackathon discusses how artificial intelligence (AI) and the Internet of Things (IoT) will impact life sciences  The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is calling upon the industry to support the ‘Lab of the Future’ […]

IQVIA Establishes Alliance with MuleSoft to Deliver Innovative Integration Technology to Life Sciences Companies

March 15, 2018

BARCELONA, Spain–(BUSINESS WIRE)–IQVIA (NYSE: IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, today announced at the eyeforpharma conference that it has formed a strategic alliance with MuleSoft, the provider of the leading platform for building application networks. MuleSoft’s Anypoint Platform™ powers Lexi™, IQVIA’s Integration Platform […]

Ionis and Akcea Partner to Commercialize Inotersen for hATTR

March 15, 2018

CARLSBAD, Calif. and CAMBRIDGE, Mass., March 15, 2018 /PRNewswire/ — Ionis Pharmaceuticals (NASDAQ: IONS) (“Ionis”) and Akcea Therapeutics, Inc. (NASDAQ: AKCA) (“Akcea”), an affiliate of Ionis, today announced an exclusive, worldwide license by Ionis to Akcea for inotersen and AKCEA-TTR-LRx, formerly IONIS-TTR-LRx, in a transaction potentially worth up to approximately $1.7 billion to Ionis plus […]

Strata Oncology Announces New Partnerships with Aurora Health Care & UTHealth

March 14, 2018

Strata Precision Oncology Network™ now includes 10 healthcare systems providing no-cost tumor profiling and clinical trials system-wide ANN ARBOR, Mich., March 13, 2018 — Strata Oncology, a precision oncology company, today announced that Aurora Health Care, the largest healthcare system in Wisconsin, and University of Texas Health Sciences at Houston (UTHealth) have joined the Strata […]

IQVIA Forms Alliance with Box to Provide Revolutionary, Cloud-Based Content Management Solutions to the Life Sciences and Healthcare Industries

March 14, 2018

BARCELONA, Spain–(BUSINESS WIRE)–IQVIA™ (NYSE: IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, today announced at the eyeforpharma conference that it has entered into an alliance with Box, a leading cloud content management platform provider. The Box platform expands and strengthens IQVIA’s Platform of Platforms strategy […]

Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson’s Disease

March 13, 2018

JERUSALEM, March 12, 2018 /PRNewswire/ —   Intec Pharma Ltd. (NASDAQ, TASE: NTEC) (“Intec” or the “Company”) today announces that it has partnered with LTS Lohmann Therapie-Systeme AG (“LTS”) for the manufacture of the Company’s lead product candidate, Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) as a treatment for the severe symptoms in advanced Parkinson’s Disease patients. Under […]

PAREXEL and CHA Medical Group Partner to Enhance Early Phase Clinical Research in Korea

March 13, 2018

BOSTON, March 13, 2018 – PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea. The collaboration is designed to provide biopharmaceutical companies with comprehensive services that leverage PAREXEL’s global clinical research and regulatory expertise with CHA’s experience […]

Phenovista Chooses Science Exchange as the Primary Online Channel to Offer Phenotypic Assays to Scientists

March 12, 2018

PALO ALTO, CA, March 12, 2018 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced a partnership with Phenovista Biosciences to offer online access to its Phenotypic Assay Development Services to scientists around the globe. “Science Exchange has been a steadfast ally of ours since […]

Nightingale Health and THL Biobank to accelerate personalized medicine by analyzing 40,000 blood samples

March 12, 2018

Nightingale Health, the Finnish innovator of an internationally recognized biomarker testing technology for chronic disease screening, will analyze 40,000 blood samples from Finland’s largest biobank, THL Biobank, acting under the National Institute for Health and Welfare (THL). This initiative signifies a step towards bringing personalized medicine to Finnish healthcare. Until recently, prohibitive costs and time […]